16855011

Source:http://linkedlifedata.com/resource/pubmed/id/16855011

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205179, umls-concept:C0346647, umls-concept:C1519043, umls-concept:C1519810
pubmed:issue	8
pubmed:dateCreated	2006-8-28
pubmed:abstractText	We conducted a Phase I/II study to evaluate the local efficacy and toxicity of hyperfractionated accelerated radiotherapy (HART) combined with 5-fluorouracil (5-FU) and cisplatin (CDDP) in patients with unresectable advanced pancreatic cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0368-2811
pubmed:author	pubmed-author:DonoKeizoK, pubmed-author:InoueTakehiroT, pubmed-author:InoueToshihikoT, pubmed-author:MondenMoritoM, pubmed-author:NaganoHiroakiH, pubmed-author:NakamoriShojiS, pubmed-author:SakonMasatoM, pubmed-author:TanakaEiichiE, pubmed-author:TsujieMasanoriM, pubmed-author:UmeshitaKojiK
pubmed:issnType	Print
pubmed:volume	36
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	504-10
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16855011-Aged, pubmed-meshheading:16855011-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16855011-Cisplatin, pubmed-meshheading:16855011-Combined Modality Therapy, pubmed-meshheading:16855011-Dose Fractionation, pubmed-meshheading:16855011-Drug Administration Schedule, pubmed-meshheading:16855011-Female, pubmed-meshheading:16855011-Fluorouracil, pubmed-meshheading:16855011-Humans, pubmed-meshheading:16855011-Male, pubmed-meshheading:16855011-Maximum Tolerated Dose, pubmed-meshheading:16855011-Middle Aged, pubmed-meshheading:16855011-Neoplasm Staging, pubmed-meshheading:16855011-Neutropenia, pubmed-meshheading:16855011-Pancreatic Neoplasms, pubmed-meshheading:16855011-Remission Induction, pubmed-meshheading:16855011-Survival Rate, pubmed-meshheading:16855011-Thrombocytopenia
pubmed:year	2006
pubmed:articleTitle	Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
pubmed:affiliation	Department of Surgery and Clinical Oncology, Osaka University, Suita, Osaka, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I